Vaxxas opens Vaxxas Biomedical Facility in Brisbane to manufacture vaccines
Vaxxas, a clinical-stage biotechnology company, has announced the opening of Vaxxas Biomedical Facility, its first manufacturing facility in Brisbane, Queensland. The 60,000 square feet facility will serve as the company’s global headquarters and will aid in the scale-up of operations for the production of HD-MAP vaccines for future late-stage clinical trials and commercial products. The […]